Medical Research
Leica Biosystems Unveils its Aperio GT 450 DX Digital Pathology Sca...
- Artificial Intelligence
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Science
- Vendor products
PRESS RELEASE - 11 August, 2020 - Leica Biosystems, a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly...
Three key members of 3DHISTECH’s PANNORAMIC® scanner range, PANNORAMIC® 250 Flash III, PANNORAMIC® Scan II and PANNORAMIC® Midi II as well as their control software have been upgraded to even better serve the diverse needs of cancer and...
Glasgow, Scotland, 30th April 2020: A UK-based biotechnology firm has announced the discovery of two separate novel treatments for Covid-19 patients before they are put on ventilators. They are now urgently seeking funding of £4m to...
Huron Digital Pathology Granted US Patent for Barcoding Digital Ima...
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Government
- Informatics
- International
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Medical Research
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
St. Jacobs, Ontario, Canada – April 22, 2020 – Huron Digital Pathology announced today that it has been granted a US patent for barcoding digital images. The invention forms the basis for Huron’s image search platform. Related to the...
Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...
Inspirata gains strategic support in its initiative to allow pathology departments across the world to offer work-from-home opportunities for their pathologists during the COVID-19 pandemic crisis. Tampa, Florida (GLOBE NEWSWIRE) -- Cancer...































